P. M. Wilkinson
Impact in
- Oncology top 5%
- Neutropenia and Cancer Infections
- Cancer Treatment and Pharmacology
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation
Papers in
-
- Safe Handling of Antineoplastic Drugs 3
-
- Chemotherapy-induced organ toxicity mitigation 4
- Co-authors
- John A. Radford (4 shared papers)Kevin Y. Kane (2 shared papers)Howard Gurney (2 shared papers)Ruth Pettengell (2 shared papers)D. Crowther (2 shared papers)DP Deakin (2 shared papers)J. Bentley (2 shared papers)R.D. James (2 shared papers)
- Journals
- British Journal of Cancer (3 papers)Cancer Chemotherapy and Pharmacology (2 papers)Blood (2 papers)British Journal of Clinical Pharmacology (1 paper)International Journal of Gynecological Cancer (1 paper)
- Partner nations
- United KingdomNetherlands
In The Last Decade
P. M. Wilkinson
14 papers receiving 831 citations
Peers
Comparison fields: 5 of 65
- Oncology 582
- Hematology 178
- Emergency Medicine 88
- Pathology and Forensic Medicine 170
- Dermatology 54
Countries citing papers authored by P. M. Wilkinson
This map shows the geographic impact of P. M. Wilkinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. M. Wilkinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. M. Wilkinson more than expected).
Fields of papers citing papers by P. M. Wilkinson
This network shows the impact of papers produced by P. M. Wilkinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. M. Wilkinson. The network helps show where P. M. Wilkinson may publish in the future.
Co-authors
The 25 scholars most cited alongside P. M. Wilkinson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 357 | |
| 2 | 1992 | 291 | |
| 3 | 1983 | 89 | |
| 4 | 1989 | 65 | |
| 5 | 1990 | 21 | |
| 6 | 1991 | 15 | |
| 7 | 1990 | 14 | |
| 8 | Recombinant human erythropoietin and platinum-based chemotherapy in advanced ovarian cancer. | 2006 | 13 |
| 9 | 1988 | 12 | |
| 10 | 2006 | 10 | |
| 11 | 1975 | 7 | |
| 12 | 1977 | 5 | |
| 13 | Clinical cancer, principal sites | 1979 | 3 |
| 14 | 1976 | 1 |
About P. M. Wilkinson
P. M. Wilkinson is a scholar working on Occupational Therapy, Pathology and Forensic Medicine, Oncology, Hematology and Clinical Biochemistry, having authored 14 papers that have together received 903 indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (4 papers), Chemotherapy-induced organ toxicity mitigation (4 papers), Safe Handling of Antineoplastic Drugs (3 papers), Bacterial Identification and Susceptibility Testing (2 papers), Hematological disorders and diagnostics (2 papers), Renal and related cancers (2 papers), Blood disorders and treatments (2 papers) and Acute Myeloid Leukemia Research (1 paper). The work is most often cited by research in Oncology (582 citations), Hematology (178 citations), Emergency Medicine (88 citations), Pathology and Forensic Medicine (170 citations) and Dermatology (54 citations). P. M. Wilkinson has collaborated with scholars based in United Kingdom and Netherlands. Frequent co-authors include John A. Radford, Kevin Y. Kane, Howard Gurney, Ruth Pettengell, D. Crowther, DP Deakin, J. Bentley, R.D. James, Roger James and J. M. Margison. Their work appears in journals such as British Journal of Cancer, Cancer Chemotherapy and Pharmacology, Blood, British Journal of Clinical Pharmacology and International Journal of Gynecological Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.